Ulrik B. Nielsen, Director at MERRIMACK PHARMACEUTICALS INC (MACK), sold 40,000 shares at $12.88 ($515K) on 2015-04-20, disclosed to the SEC on 2015-04-20.
Scheduled sale ($515k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| MACK | SELL | 2017-09-13 | $310K | — | Filing → |
| MACK | SELL | 2015-07-22 | $214K | — | Filing → |
| MACK | SELL | 2015-06-19 | $481K | — | Filing → |